Skip to main content
TSUMURA & CO. logo

TSUMURA & CO. — Investor Relations & Filings

Ticker · 4540 ISIN · JP3535800001 LEI · 3538005RS3M1OVJLC663 T Manufacturing
Open in API
Filings indexed 68 across all filing types
Latest filing 2025-11-11 Regulatory Filings
Country JP Japan
Listing T 4540

About TSUMURA & CO.

https://www.tsumura.co.jp/english/

TSUMURA & CO. is a developer and manufacturer of pharmaceuticals derived from natural substances, specializing in Kampo medicine, a traditional form of Japanese herbal medicine. The company's portfolio includes a wide range of prescription Kampo formulations, which are delivered to patients through medical institutions, as well as over-the-counter (OTC) Kampo medicines and other wellness products such as herbal bath salts. Tsumura manages a comprehensive value chain, controlling the entire process from the procurement of raw herbal materials to the production of finished granular formulations and extracts. The company's approach integrates traditional knowledge with modern scientific research and quality control standards to provide treatments across various therapeutic areas, aiming to achieve harmony between mind and body.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 90
2025-11-11 Japanese
半期報告書－第90期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Tsumura & Co. with the Kanto Local Finance Bureau in Japan. It covers the interim accounting period from April 1, 2025, to September 30, 2025. It contains comprehensive financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-11-11 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Status of Acquisition of Treasury Shares' (自己株券買付状況報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's share buyback activity for the period of August 2025. This falls directly under the category of 'Transaction in Own Shares' (POS).
2025-09-10 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Purchase of Own Shares' (自己株券買付状況報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's share repurchase activity for the period of July 2025, including the number of shares acquired and the total cost. This falls directly under the category of 'Transaction in Own Shares' (POS).
2025-08-05 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document header explicitly states the filing type as '自己株券買付状況報告書' (Report on the Status of Treasury Stock Acquisition). The legal basis cited is Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act. The content details the acquisition status of treasury stock ('自己株式') during the reporting period (June 1 to June 30, 2025), including the total amount acquired and the remaining balance. This directly corresponds to regulatory filings concerning share repurchases or transactions in own shares. Based on the provided definitions, 'Transaction in Own Shares' (Code: POS) is the most appropriate classification for reports detailing share buybacks/repurchases.
2025-07-08 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following the resolutions made at the Annual General Meeting (AGM) held on June 27, 2025. Section 2 details the resolutions, including dividend approval and the election/re-election of directors and auditors, along with the voting results (votes for, against, abstentions, and approval percentages). This content perfectly matches the definition of reporting the results of a shareholder meeting vote. The most specific code for reporting official results from shareholder votes is 'DVA' (Declaration of Voting Results & Voting Rights Announcements). Although it relates to an AGM, the core content is the voting outcome report, not the AGM presentation materials (AGM-R).
2025-07-01 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.